Post-transplantation diabetes mellitus; frequency and related risk factors: A single center study

被引：0

作者：

Ghafari, Ali ^{[1
]}

PourAli, Reza ^{[1
]}

Sepehrvand, Nariman ^{[1
]}

Hatami, Sanaz ^{[1
]}

Modarres, Vanooshe ^{[1
]}

机构：

[1] Urmia Univ Med Sci, Imam Khomeini Training Hosp, Dept Internal Med, Orumiyeh, Iran

来源：

SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION | 2010年 / 21卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Post-transplantation Diabetes Mellitus (PTDM) is a serious complication after organ transplantation, which could lead to cardiovascular morbidity and mortality. The rate of PTDM increased in recent years, probably due to new immunosuppressive drugs such as Tacrolimus. In this study, we retrospectively evaluated the frequency of PTDM and related risk factors in 644 non diabetic patients who underwent renal transplantation. Data was analyzed by chi-square and Fishers exact test in SPSS software ver11.5. Among 644 patients PTDM developed in 10.2% similar to literature. PTDM was significantly correlated to age (P value = 0.000), positive familial history (P= 0.003) and HBV infection (P= 0.046). In conclusion, PTDM is not uncommon in Iranian patients and a positive family history of diabetes, HBV infection and older age increases the likelihood to develop PTDM.

引用

页码：842 / 845

页数：4

共 14 条

[1] Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus [J].

Bloom, RD ;

Rao, V ;

Weng, F ;

Grossman, RA ;

Cohen, D ;

Mange, KC .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05) :1374-1380

[2] Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation [J].

Bouchta, NB ;

Ghisdal, L ;

Abramowicz, D ;

Broeders, N ;

Surquin, M ;

Hoang, AD ;

Wissing, KM .

TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) :1857-1860

[3] Patient survival after renal transplantation: IV. Impact of post-transplant diabetes [J].

Cosio, FG ;

Pesavento, TE ;

Kim, S ;

Osei, K ;

Henry, M ;

Ferguson, RM .

KIDNEY INTERNATIONAL, 2002, 62 (04) :1440-1446

[4] Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years [J].

Cosio, FG ;

Pesavento, TE ;

Osei, K ;

Henry, ML ;

Ferguson, RM .

KIDNEY INTERNATIONAL, 2001, 59 (02) :732-737

[5] Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients [J].

Foo, SM ;

Wong, HS ;

Morad, Z .

TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) :2139-2140

[6] Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature [J].

Ghisdal, Lidia ;

Ben Bouchta, Nora ;

Broeders, Nilufer ;

Crenier, Laurent ;

Hoang, Anh-Dung ;

Abramowicz, Daniel ;

Wissing, Karl Martin .

TRANSPLANT INTERNATIONAL, 2008, 21 (02) :146-151

[7] New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis [J].

Heisel, O ;

Heisel, R ;

Balshaw, R ;

Keown, P .

AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (04) :583-595

[8] Diabetes mellitus after kidney transplantation in the United States [J].

Kasiske, BL ;

Snyder, JJ ;

Gilbertson, D ;

Matas, AJ .

AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (02) :178-185

[9] Posttransplantation diabetes - A systematic review of the literature [J].

Montori, VM ;

Basu, A ;

Erwin, PJ ;

Velosa, JA ;

Gabriel, SE ;

Kudva, YC .

DIABETES CARE, 2002, 25 (03) :583-592

[10] Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine [J].

Romagnoli, J. ;

Citterio, F. ;

Nanni, G. ;

Favi, E. ;

Tondolo, V. ;

Spagnoletti, G. ;

Salerno, M. Paola ;

Castagneto, M. .

TRANSPLANTATION PROCEEDINGS, 2006, 38 (04) :1034-1036

← 1 2 →